Patel Snehal
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $131.6M based on current market prices.
Holdings by Company
GLSIJan 13, 2026
Current Shares5.60M
Value$131.64M
Net Activity+634.2K
Bought: 634.2KSold: 0
Transaction History
Showing 10 filings (page 3)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,500 | $13.18 | $72,490.00 | - | |
| Jul 23, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $15.89 | $23,835.00 | - | |
| Jun 13, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 174,825 | $14.30 | $2,499,997.50 | +3.3% | |
| Apr 1, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,000 | $19.08 | $57,240.00 | - | |
| Mar 22, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,500 | $19.98 | $49,950.00 | - | |
| Mar 20, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $17.68 | $26,520.00 | - | |
| Mar 5, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 30,500 | $12.49 | $380,945.00 | +0.6% | |
| Mar 4, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 4,100 | $13.03 | $53,423.00 | - | |
| Feb 16, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 10,800 | $11.16 | $120,528.00 | +0.2% | |
| Feb 15, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 12,700 | $11.07 | $140,589.00 | +0.2% |